Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial-Reference-Cited by-同舟云学术

Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial

Published:2007-07-05 Issue:9 Volume:21 Page:1907-1914
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Tavernier E, ,Boiron J-M,Huguet F,Bradstock K,Vey N,Kovacsovics T,Delannoy A,Fegueux N,Fenaux P,Stamatoullas A,Tournilhac O,Buzyn A,Reman O,Charrin C,Boucheix C,Gabert J,Lhéritier V,Vernant J-P,Dombret H,Thomas X

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2404824.pdf

Reference43 articles.

1. Durrant IJ, Prentice HG, Richards SM . Intensification of treatment for adults with acute lymphoblastic leukaemia: results of UK medical research council randomized trial UKALL XA. medical research council working party on leukaemia in adults. Br J Haematol 1997; 99: 84–92.

2. Fiere D, Lepage E, Sebban C, Boucheix C, Gisselbrecht C, Vernant JP et al. Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. J Clin Oncol 1993; 11: 1990–2001.

3. Hoelzer D, Thiel E, Ludwig WD, Löffler H, Büchner T, Freund M et al. Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84). Leukemia 1993; 7 (Suppl 2): S130–S134.

4. Larson RA, Dodge RK, Burns CP, Lee EJ, Stone RM, Schulman P et al. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811. Blood 1995; 85: 2025–2037.

5. Mandelli F, Annino L, Rotoli B, for the GIMEMA Cooperative Group. The GIMEMA ALL 0183 trial, analysis of 10-year follow-up. Br J Haematol 1996; 92: 663–672.

Cited by 231 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical efficacy of a daratumumab-based regimen in relapsed/refractory acute leukemia: a single-center experience;Annals of Hematology;2024-07-24

2. Management of ALL in adults: 2024 ELN recommendations from a European expert panel;Blood;2024-05-09

3. Flotetuzumab as a salvage immunotherapy in advanced CD123-positive hematological malignancies, a phase 1 pilot study;Leukemia & Lymphoma;2024-04-17

4. Investigates the genetic types of acute lymphoblastic leukemia in full remission Indonesian patients: a cross-sectional analysis;American Journal of BioMedicine;2024-04-11

5. Diagnostic and therapeutic advances in adults with acute lymphoblastic leukemia in the era of gene analysis and targeted immunotherapy;The Korean Journal of Internal Medicine;2024-01-01